BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6337541)

  • 1. Excessive insulin therapy: biochemical effects and clinical repercussions. Current concepts of counterregulation in type I diabetes.
    Wilson DE
    Ann Intern Med; 1983 Feb; 98(2):219-27. PubMed ID: 6337541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
    Cryer PE; Gerich JE
    N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine responses and their interactions with other glucoregulatory hormones.
    Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relevance of glucose counterregulatory systems to patients with insulin-dependent diabetes mellitus.
    Cryer PE; White NH; Santiago JV
    Endocr Rev; 1986 May; 7(2):131-9. PubMed ID: 2873031
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucose counterregulation in normal and diabetic man.
    Cryer PE
    Clin Physiol; 1985; 5 Suppl 5():61-5. PubMed ID: 3914389
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoglycemia in diabetes.
    Cryer PE; Davis SN; Shamoon H
    Diabetes Care; 2003 Jun; 26(6):1902-12. PubMed ID: 12766131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus.
    Gerich JE
    Diabetes; 1988 Dec; 37(12):1608-17. PubMed ID: 3056759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-morning hyperglycemia in diabetic individuals treated with continuous subcutaneous insulin infusion.
    Geffner ME; Frank HJ; Kaplan SA; Lippe BM; Levin SR
    Diabetes Care; 1983; 6(2):135-9. PubMed ID: 6682750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Somogyi phenomenon. Sacred cow or bull?
    Raskin P
    Arch Intern Med; 1984 Apr; 144(4):781-7. PubMed ID: 6370162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in humans.
    Cryer PE; Tse TF; Clutter WE; Shah SD
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E198-205. PubMed ID: 6147094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of counterregulatory hormones on kinetic response to ingested glucose in dogs.
    Saccà L; Cicala M; Corso G; Ungaro B; Sherwin RS
    Am J Physiol; 1981 May; 240(5):E465-73. PubMed ID: 7235005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of duration of hypoglycemia on the hormonal counterregulatory response in normal subjects.
    Kerr D; MacDonald IA; Tattersall RB
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1118-22. PubMed ID: 2656734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose counterregulation: prevention and correction of hypoglycemia in humans.
    Cryer PE
    Am J Physiol; 1993 Feb; 264(2 Pt 1):E149-55. PubMed ID: 8447379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hierarchy of physiological responses to hypoglycemia: relevance to clinical hypoglycemia in type I (insulin dependent) diabetes mellitus.
    Cryer PE
    Horm Metab Res; 1997 Mar; 29(3):92-6. PubMed ID: 9137976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal blood glucose control in type I diabetes mellitus.
    Bolli GB; Perriello G; Fanelli CG; De Feo P
    Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.
    Eigler N; Saccà L; Sherwin RS
    J Clin Invest; 1979 Jan; 63(1):114-23. PubMed ID: 762240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.